local_hospital

Wojewodzki Szpital Dla Nerwowo I Psychicznie Chorych Im. Dr J. Bednarza

Address
lock Available on a paid plan

Wojewodzki Szpital Dla Nerwowo I Psychicznie Chorych Im. Dr J. Bednarza - Psychiatric Research Center

Wojewodzki Szpital Dla Nerwowo I Psychicznie Chorych Im. Dr J. Bednarza (Dr. J. Bednarz Provincial Hospital for Nervous and Mental Diseases) is a specialized psychiatric facility conducting advanced clinical research in severe mental health disorders. The center demonstrates expertise in investigating both innovative pharmacological interventions and novel therapeutic approaches for complex psychiatric conditions.

  • Bipolar disorder treatment optimization including adjunctive anti-inflammatory therapies
  • Schizophrenia research with focus on cognitive impairment management
  • Long-term safety monitoring and extended follow-up studies in psychiatric populations

The research center's portfolio includes studies examining acetylsalicylic acid as add-on therapy for bipolar affective disorder, reflecting contemporary interest in neuroinflammatory pathways in mood disorders. Additionally, the facility participates in international phase III programs evaluating novel treatments such as Iclepertin for cognitive impairment in schizophrenia, demonstrating commitment to addressing significant unmet needs in psychiatric care through rigorous clinical investigation and comprehensive safety assessment.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
2
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
2
Outperforms 43% of sites
public
Therapeutic diversity
2areas
Outperforms 53% of sites
groups
Sponsor diversity
2sponsors
Outperforms 44% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Wojewodzki Szpital Dla Nerwowo I Psychicznie Chorych Im. Dr J. Bednarza

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety Evaluation of Low-Dose Acetylsalicylic Acid as Adjunctive Therapy in Bipolar Affective Disorder: A Randomized, Double-Blind, Placebo-Controlled TrialInstytut Psychiatrii I NeurologiiPhase IIRecruitingMay 2023

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Acetylsalicylic Acid1Unknown2023-05-192023-05-19

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.